FibroBiologics Inc. Common Stock

FBLG | NASDAQ

$1.36

$0 (0.00%)

Sep 22, 2026, 1:17 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	4.89M	13.99M	9.16M	2.27M	407K	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	48K	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	300K	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	18K	16K	30K	24K	n/a
Total Current Assets	6.35M	14.23M	9.22M	2.63M	468K	n/a
Property-Plant & Equipment	3.22M	2.22M	2.61M	2.2M	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.27M	2.22M	2.61M	2.2M	n/a	n/a
Total Assets	9.62M	16.45M	11.82M	4.82M	468K	n/a
Account Payables	945K	2.7M	1.44M	493K	233K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	9.17M	362K	5.45M	1.3M	n/a
Other Current Liabilities	108K	460K	7.24M	803K	4K	n/a
Total Current Liabilities	1.76M	12.73M	9.18M	7.07M	1.76M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	1.7M	984K	1.39M	1.75M	n/a	n/a
Total Liabilities	3.46M	13.71M	10.57M	8.82M	1.76M	n/a
Total Debt	2.41M	10.55M	1.75M	7.52M	1.3M	n/a
Book Value	6.16M	2.74M	1.25M	-4M	-1.29M	n/a
Book Value Per Share	2.76	1.66	0.77	-2.46	-0.79	n/a
Common Stock	1K	n/a	1K	1K	n/a	1.17M
Retained Earnings	-54.16M	-35.52M	-24.36M	-7.87M	-2.75M	-1.17M
Comprehensive Income	n/a	n/a	n/a	1.46M	1.46M	n/a
Shareholders Equity	6.16M	2.74M	1.25M	-4M	-1.29M	n/a
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a